Defining the Border-Zone between Episodic Migraine (EM) and Chronic Migraine (CM): Medical Comorbidities in the US Population (P03.110)

CONCLUSIONS: The comorbidity profiles of HFEM have much more in common with CM than with LFEM suggesting that HFEM and CM may bear a close biological relationship.Supported by: The American Migraine Prevalence and Prevention Study is funded through a research grant to the National Headache Foundation from Ortho-McNeil Neurologics, Inc., Titusville, NJ. Additional analyses were supported by a grant from Allergan Inc., Irvine, CA, to the National Headache Foundation. Abstract development was conducted independent of financial support.Disclosure: Dr. Serrano has received research support from Allergan, ENDO Pharmaceuticals, Merck, GlaxoSmithKline, MAP Pharmaceuticals, Novartis, NuPathe, CoLucid and the National Headache Foundation. Dr. Buse has received personal compensation for activities with Allergan as a scientific advisor. Dr. Buse has received research suprrot or has support pending from Allergan, ENDO, MAP, Nupathe and Merck to the National Headache Foundation. Dr. Reed has received research support from Allergan, ENDO Pharmaceuticals, Merck, GlaxoSmithKline, MAP Pharmaceuticals, Novartis, NuPathe, CoLucid and the National Headache Foundation. Dr. Pavlovic has nothing to disclose. Dr. Vollbracht's family owns stock and/or stock options in Allergan, Inc. Dr. Sollars has nothing to disclose. Dr Lipton has received personal compensation for activities with Allergan, Inc., Boston Scientific, Bristol-Myers Squibb Company, Cognimed, Colucid, Eli Lilly & Company, eNeura Ther...

Source: Neurology - February 14, 2013 Category: Neurology Authors: Serrano, D., Buse, D., Reed, M., Pavlovic, J., Vollbracht, S., Sollars, C. M., Lipton, R. Tags: P03 Headache: Epidemiology Source Type: research